CPC G16B 30/00 (2019.02) [C12Q 1/689 (2013.01); C12Q 2535/122 (2013.01); G16B 35/00 (2019.02)] | 15 Claims |
1. A method of treating a disease or infection caused by a microorganism in a subject comprising administering to the subject a compound that inhibits the growth of a microorganism whose significance score meets or exceeds a threshold value, wherein the significance score is calculated by:
comparing sequence reads with one or more databases comprising the genetic information from a control subject of the same species and the genetic information from a plurality of microorganisms to determine whether or not a compared sequence read maps to a species comprised within the one or more databases, wherein the sequence reads are obtained by sequencing nucleic acids present in a biological sample obtained from the subject;
determining over time the number of compared sequence reads mapping to a particular microorganism and the number of compared sequence reads mapping to a species, wherein the sequence reads mapping to a species comprise sequence reads mapping to the species of the subject; and
computing a significance score for the probability of finding in the subject a compared sequence read mapping to the particular microorganism based on the number of compared sequence reads mapping to the particular microorganism and the number of compared sequence reads mapping to a species.
|